Pre-alpha 2-elastase inhibitor of the horse: a hybrid molecule between alpha 1-proteinase inhibitor and alpha 2-beta 1-glycoprotein.

The research study investigates a recently isolated molecule in horse plasma, the pre-alpha 2-elastase inhibitor, finding that this inhibitor is composed of two known molecules, the alpha 1-proteinase inhibitor and alpha 1-beta 1-glycoprotein. The research further explores the biological activity and enzyme specificity of this composite molecule.

Introduction to the Composite Molecule

• The study revolves around the pre-alpha 2-elastase inhibitor, a molecule isolated from horse plasma in the laboratory.
• Past investigations indicated that this inhibitor had initial enzyme specificity that was different from the free alpha 1-proteinase inhibitor.
• The research aimed to explore this molecule further, identifying its components and their individual biological effects.

The Constituents of the Inhibitor

• As the study unfolded, it was found that this inhibitor was a composite structure.
• It consists of two distinct molecules: the alpha 1-proteinase inhibitor and the alpha 2-beta 1-glycoprotein.

Biological Activity and Behavior

• Despite being a composite structure, the inhibitor retains biological activity.
• Immunochemical cross-reactions, i.e., the reactions that occur between an antigen and its corresponding antibody, between the pre-alpha 2-elastase inhibitor and antibodies to alpha 2-beta 1-glycoprotein plus antibodies to alpha 1-proteinase inhibitor, formed the basis of these observations.

Dissociation and Retained Activity

• An intriguing discovery was that the composite pre-alpha 2-elastase inhibitor could be dissociated into its parent components by dithiothreitol, a reducing agent.
• Post dissociation, the alpha 1-proteinase inhibitor part of the composite structure maintained its biological activity.
• This suggests the alpha 1-proteinase inhibitor may be a significant contributor to the biological activity of the composite molecule.

Conclusion

• This research enhances understanding of a new molecule’s structure and behavior, specifically, the pre-alpha 2-elastase inhibitor in horse plasma.
• Further study could provide more understanding about its role, potential functions, and implications in biochemistry and veterinary medicine.